Cerebral Microbleeds and Risk of Intracerebral Hemorrhage Post Intravenous Thrombolysis

Ramin Zand1, Georgios Tsivgoulis2, Mantinderpreet Singh3

  • 1Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee; Biocomplexity Institute, Virginia Tech, Blacksburg, Virginia.

Abstract

Insights

Patients with over 10 cerebral micro bleeds (CMBs) face a significantly higher risk of symptomatic intracerebral hemorrhage (sICH) after intravenous thrombolysis (IVT). This finding highlights CMBs as a crucial factor in predicting post-stroke complications.

Area of Science:

  • Neurology
  • Radiology
  • Stroke Medicine

Background:

  • Cerebral micro bleeds (CMBs) may increase stroke patients' risk of symptomatic intracerebral hemorrhage (sICH).
  • Previous research suggests a potential link between CMBs and adverse outcomes after intravenous thrombolysis (IVT).

Purpose of the Study:

  • To investigate the association between the presence and burden of CMBs and the occurrence of sICH after IVT.
  • To determine if CMBs identified on MRI predict sICH risk in stroke patients treated with IVT.

Main Methods:

  • Prospective, multicenter study analyzing consecutive patients treated with IVT.
  • Inclusion criteria required magnetic resonance imaging (MRI) within 24 hours of treatment.
  • CMBs defined as hypointense lesions with blooming on T2*-weighted MRI; sICH and death were outcome measures.

Main Results:

  • Of 672 patients, 103 had CMBs. sICH rates did not differ for 1-10 CMBs (5.8%) vs. no CMBs (3.5%).
  • However, sICH occurred more frequently in patients with >10 CMBs (30%) compared to those with fewer or no CMBs (P=.0009).
  • The presence of >10 CMBs independently predicted a higher likelihood of sICH (OR: 13.4, P=.0004).

Conclusions:

  • An increased risk of sICH following IVT is associated with the presence of more than 10 CMBs.
  • CMB burden, specifically >10 lesions, is a significant predictor of sICH after IVT.
  • These findings emphasize the importance of assessing CMBs for risk stratification in stroke patients receiving IVT.